Neurocrine Biosciences Inc

NASDAQ: NBIX
$125.65
+$0.65 (+0.5%)
Closing Price on November 22, 2024

NBIX Articles

The top analyst upgrades, downgrades and initiations seen on Wednesday included AIG, Aqua America, CenterPoint Energy, Ferrari, GameStop, Medtronic, Roku, Salesforce.com and Uber Technologies.
The top analyst upgrades, downgrades and initiations seen on Monday included Amazon.com, Dover, Facebook, Lam Research, Newmont Mining, Occidental Petroleum, Six Flags, Tesla and 3D Systems.
The top analyst upgrades, downgrades and initiations seen on Thursday included Arena Pharmaceuticals, Autodesk, Coca-Cola, General Electric, Marvell, Monster Beverages, Nabors and Procter &...
Wells Fargo, Weatherford International, Huntington Bancshares, and Neurocrine Biosciences all posted new 52-week lows Wednesday.
Neurocrine Bio shares dipped on Wednesday after the company announced that its midstage Tourette syndrome study did not live up to expectations.
A series of new Stifel research reports focus on three biotech companies that have upcoming clinical data that could prove to be huge.
With 2018 coming to a close in just a few months, Merrill Lynch is taking a close look at the biotech industry and what key catalysts to expect before 2019.
The top analyst upgrades, downgrades and initiations seen on Monday include Amazon, Anthem, Constellation Brands, Hecla Mining, Nike, Overstock.com and UnitedHealth.
Four top growth stocks could be great trades for the balance of 2018 and good to hold into the coming years as they all stand to have continued revenue growth and are solid players in their...
The top analyst upgrades, downgrades and other research calls from Tuesday include Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts and Zillow.
While these four stocks are better suited for accounts that have a higher risk tolerance, they all make good sense now and all have outstanding upside potential.
While there is no guarantee that these four biotech companies are acquired, they are outstanding stocks to own in aggressive growth portfolios on their own.
The top analyst upgrades, downgrades and other research calls from Friday include Albermarle, Allergan, Boston Scientific, eBay, FedEx, Gogo, LendingTree, Nokia, UPS and Vertex Pharmaceuticals.
The top analyst upgrades, downgrades and other research calls from Wednesday include Avis Budget, Blue Apron, Chipotle Mexican Grill, Domino's, Northrop Grumman, Pepsico, Rio Tinto, T-Mobile and...
The top analyst upgrades, downgrades and other research calls from Tuesday include Accenture, Ericsson, General Motors, Phillips 66, United Rentals, Urban Outfitters, Xerox and Yum Brands.